Stay updated on Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.4, was added and the previous tag, v3.5.3, removed, indicating a deployment-level update to the page's version. This reflects an update to the site's backend/content management rather than changes to trial details.
    Difference
    0.0%
    Check dated 2026-05-15T06:12:03.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Update to the study record's status metadata, including the verifier (University of Kansas Medical Center) and the verification date (2024-04). This reflects administrative tracking rather than changes to core study content.
    Difference
    0.4%
    Check dated 2026-05-01T08:20:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page’s software/UI revision indicator was updated from v3.5.2 to v3.5.3, reflecting a backend or display version change rather than a modification to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added. Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:54.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T06:25:22.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.